REGN vs UZD · P/E 14, rev $14.34B vs rev $3.77B
Regeneron Pharmaceuticals Inc (REGN) versus Array Digital Infrastructure, I (UZD) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Array Digital Infrastructure, I (UZD) common stock listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported UZD revenue for 2024-12-31 was $3.77B. Net income was -$32.0M. Revenue was down 3.5% from 2023-12-31 to 2024-12-31. UZD currently screens at market cap $2.74B.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. UZD currently screens at market cap $2.74B.
Not investment advice. Open the REGN and UZD stock pages for the full models.
Not investment advice.